Trial intelligence / Profile preview

Early vs Intraoperative Tranexamic Acid for Hip Fracture Blood Loss

NCT05047133Phase 3Recruiting

Sponsor
Ascension
Start
Sep 2021
Primary completion
Jul 2022
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of tranexamic acid in hemorrhage, sponsored by Ascension. Started Sep 2021; status: recruiting.

02

Drugs

tranexamic acid
03

Conditions

hemorrhage

Beyond the preview

Go deeper on NCT05047133.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05047133.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call